XI
Xencor Inc
🇺🇸XNAS.XNCRUnited StatesHealthcare
$12.28USDdown -0.23 (-1.84%)ClosedDelayed2:14 AM
Price$12.28-0.23 (-1.84%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US98401F1057
- CUSIP
- 98401F105
Company
- Employees
- 260
- Headquarters
- Pasadena, United States
- Website
- https://www.xencor.com
- CEO
- Dr. Bassil I. Dahiyat Ph.D.
Market
- Shares outstanding
- 74.4M
- Market cap
- $900.6M
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- $900.6M
- EPS LTM
- -$2.15
- P/E LTM
- -5.70calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $104.97M-36.05%down year on year
- Net income
- -$163.33M+8.76%up year on year
- Gross margin
- 43.31%+43.55%up year on year
- Free cash flow
- -$208.29M-47.91%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.